<Disease><Name>3-METHYLGLUTACONIC ACIDURIA (TYPE VII)</Name><Synonym>3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN</Synonym><OMIM><Number>616271</Number><URL>http://omim.org/entry/616271</URL></OMIM><Orphanet><Number>445038</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=445038</URL></Orphanet><Protein><Number>Caseinolytic peptidase B protein homolog</Number><URL>http://www.uniprot.org/uniprot/Q9H078</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>11q13.4</Gene><ICD>E71.1</ICD><Summary>very rare;autosomal recessive;mutation in the CLPB gene</Summary><Symptoms><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>1966</id><symptom>cerebellar atrophy or hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1969</id><symptom>extrapyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2038</id><symptom>neutropenia (decreased neutrophils)</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1576</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>increased</value><min>3.40</min><max>9.50</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1709</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>increased</value><min>17.00</min><max>26.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>83</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1342</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1343</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1156</id><name>3-Methylglutaconic acid</name><specimen>amnion fluid</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>adult</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>3895</id><title>Novel CLPB mutation in a patient with 3-methylglutaconic aciduria causing severe neurological involvement and congenital neutro</title><author>Kiykim A,</author><journal>Clin Immunol</journal><year>2016</year><book /><volume>165</volume><number>0</number><pages>1-3</pages><co_aut>et al.</co_aut></literature><literature><id>3896</id><title>MEGCANN: A new disorder in the Rish Traveller population</title><author>Fitzsimons PE,</author><journal>SSIEM 2016 Annaual Symposium, Rome, Italy, September 2016</journal><year>2016</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3466</id><title>CLPB variants associated with autosomal-recessive mitochondrial disorder with cataract, neutropenia, epilepsy, and methylglutaconic aciduria</title><author>Saunders C.</author><journal>Am J Hum Genet</journal><year>2015</year><book /><volume>96</volume><number>2</number><pages>258-265</pages><co_aut>et al.</co_aut></literature><literature><id>3467</id><title>CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder.</title><author>Wortmann SB,</author><journal>Am J Hum Genet</journal><year>2015</year><book /><volume>96</volume><number>2</number><pages>245-257</pages><co_aut>et al.</co_aut></literature><literature><id>3468</id><title>Disruption of CLPB is associated with congenital microcephaly, severe encephalopathy and 3-methylglutaconic aciduria</title><author>Capo-Chichi JM,</author><journal>J Med Genet</journal><year>2015</year><book /><volume>52</volume><number>5</number><pages>303-311</pages><co_aut>et al.</co_aut></literature><literature><id>5165</id><title>Bi-allelic CLPB mutations cause cataract, renal cysts, nephrocalcinosis and 3-methylglutaconic aciduria, a novel disorder of mi</title><author>Kanabus M,</author><journal>J Inherit Metab Dis</journal><year>2015</year><book /><volume>38</volume><number>2</number><pages>211-219</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>